PUBLICATIONS 2006

  1. Ahimastos AA, Lawler A, Reid CM, Blombery PA, Kingwell BA. Ramipril markedly improves walking ability in patients with peripheral arterial disease. Ann Intern Med 2006;144(9):660-4.
  2. Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, Chew DP, Warren R, Black A, New G, Walton A, Lew R, Shaw J, Horrigan M, Sebastian M, Yan BP, Brennan A, Meehan A, Reid C, Krum H; Melbourne Interventional Group investigators. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 2006;15(1):44-7.
  3. Alvarenga ME, Richards JC, Lambert G, Esler MD. Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med 2006;68(1):8-16.
  4. Battaglia S, Angus P, Chin-Dusting JPF. Role of the endothelium on vasoactive agents in patients with liver cirrhosis. J Gastroenterol Hepatol 2006;21(7):1189-93.
  5. Bobik A. Transforming growth factor-s and vascular disorders. Arterioscler Thromb Vasc Biol 2006;26(8):1712-20.
  6. Bukrinsky M, Sviridov D. Human immunodeficiency virus infection and macrophage cholesterol metabolism. J Leukoc Biol 2006;80(5):1044-51.
  7. Calkin AC, Allen TJ. Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention. Am J Cardiovasc Drugs 2006;6(1):15-40.
  8. Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia 2006;49(4):766-74.
  9. Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR- and  agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant 2006;21(9):2399-405.
  10. Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell BA, Dart AM. Effect of dietary supplementation with -casein A1 or A2 on markers of disease development in persons at high risk of cardiovascular disease. Br J Nutr 2006;95(1):136-44.
  11. Dart AM, Gatzka CD, Kingwell B. Letter by Dart et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study". Circulation 2006;114(15):e537.
  12. Dart AM, Gatzka CD, Kingwell BA, Jennings GL. Response to brachial and central arterial pressure. Hypertension 2006;48(1):e2.
  13. Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang Yu-Lu, Berry KL, Wing LMH, Reid CM, Ryan P, Beilin LJ, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ. Brachial blood pressure but not central arterial waveforms predict future cardiovascular events in elderly female hypertensives. Hypertension 2006;47(4):785-90.
  14. Dawson M, Mariani JA, Koulouris G, Taylor AJ, Avery S. The successful treatment of primary cardiac lymphoma with a dose dense schedule of rituximab-plus-CHOP. Ann Oncol 2006;17(1):176-7.
  15. Ditiatkovski M, Toh BH, Bobik A. GM-CSF deficiency reduces macrophage PPAR- expression and aggravates atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2006;26(10):2337-44.
  16. Du XJ, Fang L, Kiriazis H. Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol Ther 2006;111(2):434-75.
  17. Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, Finch AM, Hannan RA, Dart AM, Graham RM. Transgenic 1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res 2006;71(4):735-43.
  18. Duffy SJ, Federman J, Farrington C, Reuter DG, Richardson M, Kaye DM. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of functional mitral regurgitation in patients with heart failure. Catheter Cardivasc Interv 2006;68(2):205-10.
  19. Eikelis N, Esler M, Barton D, Dawood T, Wiesner G, Lambert G. Reduced brain leptin in patients with major depressive disorder and in suicide victims. Mol Psychiatr 2006;11(9):800-1.
  20. Esler M, Alvarenga M, Pier C, Richards J, El-Osta A, Barton D, Haikerwal D, Kaye D, Schlaich M, Guo L, Jennings G, Socratous F, Lambert G. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol 2006;20(4 Suppl):60-6.
  21. Esler M, Eikelis N. Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol 2006;100(1):11-2.
  22. Esler M, Kaye D. Sympathetic nervous system neuroplasticity. Hypertension 2006;47(2):143-4.
  23. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006;48(5):787-96.
  24. Esler M, Wiesner G. Development of the metabolic syndrome along the female biological life-path. J Hypertens 2006;24(1):43-5.
  25. Gao XM, Wong G, Wang B, Kiriazis H, Moore XM, Su YD, Dart AM, Du XJ. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006;24(8):1663-70.
  26. Gould PA, D'Agostino J, Schneider HG, Kaye DM. Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure. Eur J Heart Fail 2006;8(3):263-9.
  27. Gould PA, Mariani JA, Kaye DM. Biventricular pacing in heart failure: a review. Expert Rev Cardiovasc Ther 2006;4(1):97-109.
  28. Gould PA, Yii M, McLean C, Finch S, Marshall T, Lambert GW, Kaye DM. Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation. Pacing Clin Electrophysiol 2006;29(8):821-9.
  29. Gupta D, Al-Lamee RK, Earley MJ, Kistler P, Harris SJ, Nathan AW, Sporton SC, Schilling RJ. Cryoablation compared with radiofrequency ablation for atrioventricular nodal re-entrant tachycardia: analysis of factors contributing to acute and follow-up outcome. Europace 2006;8(12):1022-6.
  30. Hengel CL, Russell PA, Gould PA, Kaye DM. Subacute anthracycline cardiotoxicity. Heart Lung Circ 2006;15(1):59-61.
  31. Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol 2006;33(1-2):1-8.
  32. Kaye DM, Esler MD. Letter by Kaye and Esler regarding article "Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart". Circulation 2006;113(22):e844.
  33. Kemp W, Chin-Dusting J. Selective intestinal decontamination in portal hypertension. Gastroenterol Hepatol 2006;2(1):64-7.
  34. Kingwell BA, Anderson GP, Duckett SJ, Hoole EA, Jackson Pulver LR, Khachigian LM, Morris ME, Roder D, Rothell-Short J, Wilson AJ. Evaluation of NHMRC funded research completed in 1992, 1997 and 2003: gains in knowledge, health and wealth. Med J Aust 2006;184(6):282-6.
  35. Kistler PM, Earley MJ, Harris S, Abrams D, Ellis S, Sporton SC, Schilling RJ. Validation of three-dimensional cardiac image integration: use of integrated CT image into electroanatomic mapping system to perform catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006;17(4):341-8.
  36. Kistler PM, Liew G, Mond HG. Long-term performance of active-fixation pacing leads: a prospective study. Pacing Clin Electrophysiol 2006;29(3):226-30.
  37. Kistler PM, Rajappan K, Jahngir M, Earley MJ, Harris S, Abrams D, Gupta D, Liew R, Ellis S, Sporton SC, Schilling RJ. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006;17(10):1093-101.
  38. Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006;48(5):1010-7.
  39. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 2006;27(24):3045-56.
  40. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circul Physiol 2006;290(4):H1706-12.
  41. Lambert E, Hotchkin E, Alvarenga M, Pier C, Richards J, Barton D, Dawood T, Esler M, Lambert G. Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J Physiol 2006;570(3):637-43.
  42. Lambert G, Elam M, Friberg P, Lundborg C, Gao S, Berquist J, Nitescu P. Acute response to intracisternal bupivacaine in patients with refractory pain of the head and neck. J Physiol 2006;570(2):421-8.
  43. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM, Ritchie RH. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 2006;72(1):112-23.
  44. Mariani JA, Gould PA, Broughton A, Kaye DM. Cardiac resynchronisation therapy for heart failure. Intern Med J 2006;36(2):114-23.
  45. McConell GK, Kingwell BA. Does nitric oxide regulate skeletal muscle glucose uptake during exercise? Exerc Sport Sci Rev 2006;34(1):36-41.
  46. Menshikov M, Torosyan N, Elizarova E, Plakida K, Vorotnikov A, Parfyonova Y, Stepanova V, Bobik A, Berk B, Tkachuk V. Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production. J Vasc Res 2006;43(5):482-90.
  47. Murphy AJ, Sviridov D, Chin-Dusting JPF. Lipids and the endothelium: an update . Fututre Lipidol 2006;1(5):517-26.
  48. Naredi S, Lambert G, Friberg P, Zall S, Eden E, Rydenhag B, Tylman M, Bengtsson A. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006;32(12):1955-61.
  49. Nestel P. Relationship between arterial stiffness and glucose metabolism in women with metabolic syndrome. Clin Exp Pharmacol Physiol 2006;33(9):883-6.
  50. Nestel PJ, Fujii A, Allen T. The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 2006;189(2):282-7.
  51. Nigro J, Osman N, Dart AM, Little PJ. Insulin resistance and atherosclerosis. Endocr Rev 2006;27(3):242-59.
  52. Pittaway JK, Ahuja KD, Cehun M, Chronopoulos A, Robertson IK, Nestel PJ, Ball MJ. Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men. Ann Nutr Metab 2006;50(6):512-8.
  53. Plekhanova OS, Stepanova VV, Ratner EI, Bobik A, Tkachuk VA, Parfyonova YV. Urokinase plasminogen activator in injured adventitia increases the number of myofibroblasts and augments early proliferation. J Vasc Res 2006;43(5):437-46.
  54. Preovolos AC, Mennen MT, Bilney A, Mariani J, Kaye DM, Power JM. Development of a novel perfusion technique to allow targeted delivery of gene therapy--the V-Focus system. J Extra Corpor Technol 2006;38(1):51-2.
  55. Raj T, Kanellakis P, Pomilio G, Jennings G, Bobik A, Agrotis A. Inhibition of fibroblast growth factor receptor attenuates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006;26(8):1845-51.
  56. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia I: clinical features, diagnosis, mechanisms, and anatomic location. Pacing Clin Electrophysiol 2006;29(6):643-52.
  57. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia II: management. Pacing Clin Electrophysiol 2006;29(7):769-78.
  58. Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism 2006;55(1):90-5.
  59. Shaw JA, White AJ, Reddy R, Duffy SJ, Walton AS, Kingwell BA, Dart AM. Evaluation of differences in coronary plaque mechanical behaviour in individuals with and without Type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2006;26(12):2826-7.
  60. Stocker R, Pollicino C, Gay CA, Nestel P, Colquhoun D, Whiting M, Tonkin A, Sullivan D, Simes J. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. Atherosclerosis 2006;187(1):198-204.
  61. Sviridov D, Chin-Dusting J, Nestel P, Kingwell B, Hoang A, Olchawa B, Starr J, Dart A. Elevated HDL cholesterol is functionally inefficient in cardiac transplant recipitents; evidence for impaired reverse cholesterol transport. Transplantation 2006;81(3):361-6.
  62. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Gross M, Dietz R, Friedrich MG. Elective percutaneous coronary intervention acutely impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J 2006;151(4):891.e1-7.
  63. Thomas MC, Zimmet P, Shaw JE. Identification of obesity in patients with Type 2 diabetes from Australian primary care: the NEFRON-5 study. Diabetes Care 2006;29(12):2723-5.
  64. Watts G, Chan D, Ooi E, Nestel P, Beilin Lj, Barrett P. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies. Clin Exp Pharmacol Physiol 2006;33(9):877-82.
  65. Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, Chin-Dusting J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res 2006;98(1):149-56.
  66. Yan BP, Ajani AE, Duffy SJ, New G, Horrigan M, Szto G, Walton A, Eccleston D, Lefkovits J, Black A, Sebastian M, Brennan AL, Reid CM, Clark DJ. Use of drug-eluting stents in Victorian public hospitals. Med J Aust 2006;185(7):363-7.
  67. Yang Z, Kaye DM. Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects. Trends Cardiovasc Med 2006;16(4):118-24.
  68. Yap KS, Gould P, Kalff V, Kaye DM, Esmore D, Kelly MJ. Evaluation of sympathetic re-innervation in heterotopic cardiac transplants by iodine-123-metaiodobenzylguanidine (I-123-MIBG) imaging. J Heart Lung Transplant 2006;25(8):977-80.
  69. Zhang WZ, Kaye DM. Does arginase activity in vitro represent that in vivo? Hypertension 2006;48(4):E14.
  70. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability. Role of arginine metabolism and oxidative stress. Hypertension 2006;48(2):278-85.
  71. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Response to cigarettes and ADMA: the smoke hasn't cleared yet. Hypertension 2006;48(4):E21.

BOOK CHAPTERS

  1. Kingwell BA. Statins and arterial stiffness. In: Safar ME, O'Rourke ME (eds) Handbook of Hypertension: Arterial Stiffness in Hypertension, Vol 23. 2006. Elsevier, UK. pp559-566.
  2. Kingwell BA, Cameron JD. Non-pharmacological treatment for increased arterial stiffness. In: Safar ME, O'Rourke ME (eds) Handbook of Hypertension: Arterial Stiffness in Hypertension, Vol 23. 2006. Elsevier, UK. pp567-580.
  3. Safar ME, Kass D, Asmar R, Kingwell BA. Basis for a de-stiffening strategy of antihypertensive drugs. In: Safar ME, O'Rourke ME (eds) Handbook of Hypertension: Arterial Stiffness in Hypertension, Vol 23. 2006. Elsevier, UK. pp527-536.

I am a PATIENT

i-am-a-patient

Consultation in the Heart Centre is only by referral from a Medical Practitioner.

I am a HEALTH PROFESSIONAL

i-am-a-health-professional

Please follow the link to find further information

Your STORIES

our-stories-home

‘This just doesn’t happen to people like me.’  aged 50...

Support US

the-alfred-foundation

Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login